NHS National Pharmaceuticals Generic Products Wave 15b

Description

NHS National Pharmaceuticals Generic Products - Wave 15b
Offer reference number: CM/PHG/23/5698
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
FIND A TENDER (FTS) Reference number: 2025/S 000-005420
Potential periods of call-offs under the framework agreement:
CM/PHG/23/5698/01 - Orals (plus non-parenteral) Products
CESW: (Midlands and Southwest): 1st October 2025 to 31st May 2027 (20 months)
NWLN: (Northwest and London North): 1st October 2025 to 31st May 2027 (20 months)
LSNE: (London South and Northeast): 1st October 2025 to 31st May 2027 (20 months)

CM/PHG/23/5698/02 - Hospital Only Products
DCE (Midlands) & DSW (Southwest): 1st October 2025 to 30th September 2027 (24 months)

CM/PHG/23/5698/03 - Hospital Only (Housekeeping) Products
DLS (London South) & DNE (Northeast): 1st October 2025 to 31st May 2026 (8 months)
DNW (Northwest) & DLN (London North): 1st October 2025 to 31st January 2027 (16 months)
DCE (Midlands) & DSW (Southwest): 1st October 2025 to 31st May 2026 (8 months)